Conjugated compounds comprising cysteine-engineered antibodies
AssigneeMedImmune, LLC
InventorsChangshou GAO, Godfrey RAINEY, Cuihua GAO
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedImmune, LLC
InventorsChangshou GAO, Godfrey RAINEY, Cuihua GAO
Estimating the term…
This disclosure provides conjugate compounds comprising antibodies and fragments thereof engineered with one or more reactive cysteine residues and more specifically to conjugate compounds with therapeutic or diagnostic applications. The conjugate compounds comprise cysteine-engineered antibodies or fragments thereof conjugated, for example, with chemotherapeutic drugs, toxins, and detection labels such as radionuclides or fluorophores. The disclosure also provides methods of using the disclosed conjugate compounds for in vitro, in situ, ex vivo, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
A method for making a conjugate compound comprising:
A method for making a conjugate compound comprising:
A nucleic acid encoding a cysteine-engineered antibody or Fc fusion protein, wherein the Fc domain of the antibody or Fc fusion protein comprises a cysteine amino acid insertion between positions 239 and 240, wherein the amino acid position numbering is according to the EU index as set forth in Kabat.
Dependencies are inferred from the claim text.